Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-775,000
Closed -$81.6M 106
2025
Q4
$81.6M Buy
+775,000
New +$72.7M 2.77% 10
2025
Q1
Sell
-800,000
Closed -$79.6M 75
2024
Q4
$79.6M Buy
+800,000
New +$82.5M 4.72% 3
2024
Q1
Sell
-400,000
Closed -$43.6M 66
2023
Q4
$43.6M Buy
+400,000
New +$41.5M 4.62% 6

Other funds holding MRK

Vestal Point Capital's MRK Position: Q1 2026 in Review

Vestal Point Capital sold out of Merck (MRK) in Q1 2026, closing a stake of 775,000 shares — an estimated $81.6M sold.

Vestal Point Capital first reported a position in MRK in Q4 2023 and held it in 3 quarters. The position peaked at $81.6M in Q4 2025. 3,779 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Vestal Point Capital reported no remaining Merck position as of Q1 2026 after selling out during the quarter.
  • Vestal Point Capital sold 775,000 Merck shares in Q1 2026, an estimated $81.6M.
  • Vestal Point Capital first reported a position in Merck in Q4 2023 and held it in 3 quarters.
  • Vestal Point Capital's Merck position peaked at $81.6M in Q4 2025.
  • 3,779 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Vestal Point Capital's 13F filing for Q1 2026, filed 15 May 2026.